Abstract
Forskolin (FSK) is known as an up-regulator of intracellular cAMP and inhibitor of cancer growth and metastasis. The effects of FSK on the metastasis potential and its mechanisms were studied using a human hepatocarcinoma cell line, H7721. It was found that FSK stimulated cell growth, increased cAMP in the cells, and enhanced the metastasis-related phenotypes, including adhesion to laminin (Ln) and human umbilical vein epithelial cells (HUVEC), chemotactic migration and invasion. These effects were supposed to result from the increase of the SLex expression induced by FSK, since only the monoclonal antibody of SLex showed a significant attenuation of the enhanced metastasis-associated phenotypes. Using H7721 cells transfected with the sense or antisense cDNA of protein kinase B (PKB) and some inhibitors of signal transduction, it was discovered that FSK up-regulated the expression of SLex via PKB, but it was independent of phosphotidylinositide-3-kinase (PI-3K). A subtype of atypical protein kinase C (α-PKC) might also participate in the up-regulation of SLex expression by FSK, and cAMP/PKA pathway is a negative regulator of SLex expression on H7721 cells. It can be concluded that FSK shows a metastasis-promoting effect ex vivo.
Similar content being viewed by others
References
Metzger H, Linder E: The positive inotropic-acting forskolin, a potent adenylate cyclase activator. Arzneimittle-Forschung 31: 1248-1250, 1981
Seamon KB, Padgett W, Daly JW: Forskolin: Unique diterpene activator of adenylate cyclase in membranes and intact cells. Proc Natl Acad Sci USA 78: 3363-3367, 1981
Schimmer BP, Schulz P: The roles of cAMP and cAMP-dependent protein kinase in forskolin's actions on Y1 adrenocortical tumor cells. Endocr Res 11: 199-209, 1985
Gamet L, Murat JC, Remaury A, Remesy C, Valet P, Paris H, Denis-Pouxviel C: Vasoactive intestinal peptide and forskolin regulate proliferation of the HT29 human colon adenocarcinoma cell line. J Cell Physiol 150: 501-509, 1992
Lockwood AH, Murphy SK, Borislow S, Lazarus A, Pendergast M: Cellular signal transduction and reversal of malignancy. J Cell Biochem 33: 237-255, 1987
Boghaert ER, Simpson J, Jacob RJ, Lacey T, Walsh JW, Zimmer SG: The effect of dibutyl cAMP on morphological differentiation, growth and invasion in vitro of hamster brain-tumor cell line. A comparative study of db-cAMP effects in 2 and 3 dimensional cultures. Int J Cancer 47: 162-167,1991
Hordijk PL, Verlaan I, Jalink K, Van Corvan EJ, Moolenaar WH: cAMP abrogates the p21ras-mitogen-activated protein kinase pathway in fibroblasts. J Biol Chem 269: 3534-3538, 1994
Chai XY, Qi H, Chen HL: Protein kinase and cell differentiation. Inhibition of tyrosine protein kinase by two inducers of differentiation. Chinese Biochem J 9: 162-167, 1993
Chai XY, Chen HL: Expression of oncogenes during induced differentiation of human hepatocarcinoma cell line. Chin J Cancer Res 6: 3-8, 1994
Liu F, Qi HL, Chen HL: Regulation of differentiation-and proliferation-inducers on Lewis antigens, α-fucosyltransferase and metastatic potential in hepatocarcinoma cells. Brit J Cancer 268: 3501-3512, 2001
Dong SC, Ren JX, Yang XP, Gu JX, Chen HL: Regulation of N-acetylglucosaminyl-transferase V and III by differentiation inducers and proliferation stimulator. Chinese J Biochem Biophys 26: 535-540, 1994
Brockhausen I, Narasimhan S, Schachter H: The biosynthesis of highly branched N-glycans. Studies on the sequential pathway and functional role of N-acetylglucosaminyl-transferase I, II, III, IV, V and VI. Biochimie 70: 1521-1533, 1988
Dennis JW, Laferte S: Tumor cell surface carbohydrate and the metastatic phenotype. Cancer Metastasis Rev 5: 185-204, 1987
Fernandes B, Sagman U, Auger M, Demetrio M, Dennis JW: β1,6 branched oligosaccharides as a marker of tumor progression in human breast and neoplasia. Cancer Res 51: 718-723, 1991
Varki LA: Selectin ligands. Proc Natl Acad Sci USA 91: 7390-7397, 1994
Hakomori SI: Tumor malignancy defined by aberrant glycosylation and sphingo (glyco) lipid metabolism. Cancer Res 56: 5309-5318, 1996
Kansas GS: Selectins and their ligands: Current concepts and controversies. Blood 88: 3259-3287, 1996
Takada A, Ohmori K, Yoneda T, Tsuyuoka K, Hasegawa A, Kiso M, Kannagi R: Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res 53: 354-361, 1993
Liu F, Qi HL, Zhang Y, Zhang XY, Chen HL: Transfection of c-erbB2/neu gene up-regulates the expression of sialyl Lewis X, α1,3 fucosyl-transferase VII and metastatic potential in human hepatocarcinoma cell line. Eur J Biochem 268: 3501-3512, 2001
Welch DR: Technical considerations for studying cancer metastasis in vivo. Clin Exp Metastasis 15: 272-306, 1997
Guo HB, Shen ZH, Huang CX, Huang Y, Chen HL: Modification on the basal activity of N-acetylglucosaminyltransferase V by phosphatidylinositol-3-kinase/protein kinase B signaling pathways in human hepatocarcinoma cells. Glycoconj J 17: 315-322, 2000
Liu F, Qi HL, Chen HL: Effects of all-trans retinoic acid and epidermal growth factor on the expression of nm23-H1 in human hepatocarcinoma cells. J Cancer Res Clin Oncol 126, 85-90, 2000
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin-phenol reagent. J Biol Chem 193: 265-271, 1951
Kudo T, Ikehara Y, Togayachi A, Morozumi K, Watanabe M, Nakamura M, Nishihara S, Narimatsu H: Up-regulation of a set of glycosyltransferase genes in human colorectal cancer. Lab Invest 78: 797-811, 1998
Cohen P, Alessi DR, Cross DAE: PDK-1, one of the missing links in insulin transduction. FEBS Lett 410: 3-10, 1997
Zhou X, Lu X, Richard C, Xiong W, Litchfield DW, Bittman R, Authur G: 1-O-octadecyl-2-metyl-glycerophophocholine inhibits the transduction of growth signals via the MAPK cascade in cultured MCF-7 cells. J Clin Invest 98: 937-944, 1996
Powis G, Seewald MJ, Gratas C, Melder D, Riebow J, Modest EJ: Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues. Cancer Res 52: 2835-2840, 1992
Nakamura SI: Phosphatidylcholine hydrolysis and protein kinase C activation for intracellular signaling network. J Lipid Mediator Cell Signal 14: 197-202, 1996
Herbert JM, Augereau JM, Gleye J, Maffrand JP: Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172: 993-999, 1990
Kent KC, Mii S, Harrington EO, Chang JD, Mallette S, Ware JA. Requirement for protein kinase C activation in basic fibroblast growth factor-induced human endothelial cell proliferation. Circ Res 77: 231-238, 1995
Guo HB, Zhang QS, Chen HL: Effect of H-ras and v-sis overexpression on the N-acetylglucosaminyltransferse V and metastasis-related phenotypes in human hepatocarcinoma cells. J Cancer Res Clin Oncol 126: 263-270, 2000
Guo HB, Liu F, Zhao JH, Chen HL: Down-regulation of N-Acetylglucosaminyl-transferase V by tumorigenesis-or metastasis-suppressor gene and its relation to metastatic potential of human hepatocarcinoma cells. J Cell Biochem 79: 370-385, 2000
Agarwal KC, Parks RE Jr: Forskolin: A potential antimetastatic agent. Int J Cancer 32: 801-804, 1983
Westermann P, Knoblich M, Maier O, Lindschau C, Haller H: Protein kinase C bound to the Golgi apparatus supports the formation of constitutive transport vesicles. Biochem J 320: 651-658, 1996
Landanna C, Mochly-Rosen D, Liron T, Constantin G, Butcher EC: Evidence of zeta protein kinase C involvement in polymorphonuclear neutrophile integrin-dependent adhesion and chemotaxis. J Biol Chem 273: 30306-30315, 1998
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wu, Sl., Ma, J., Qi, Hl. et al. Forskolin up-regulates metastasis-related phenotypes and molecules via protein kinase B, but not PI-3K, in H7721 human hepato-carcinoma cell line. Mol Cell Biochem 254, 193–202 (2003). https://doi.org/10.1023/A:1027392212341
Issue Date:
DOI: https://doi.org/10.1023/A:1027392212341